Diagnostics Q2 Revenue USD 200 Thousand
Aug 14 (Reuters) - Co-Diagnostics Q2 operating expenses USD 8.2 million. Q2 net income USD -7.7 million Q2 operating income USD -8.1 million Q2 adjusted EBITDA USD -7.2 million Q2 EPS USD -0.23
Recent news on Co-Diagnostics
See all newsDiagnostics' Joint Venture Cosara Diagnostics Announces Publication Of Peer-Reviewed Hpv Screening Study Using Cosara's Saragene® Test
Diagnostics - Cosara To Initiate Sales Activities Across India And South Asia
Diagnostics’ Brian Brown Stepped Down As CFO Effective September 2
Diagnostics Q2 revenue rises slightly amid international expansion
Diagnostics - Amends Equity Distribution Agreement With Maxim Group For Common Stock Sale - SEC Filing